Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Jun 7;5(6):e10992.
doi: 10.1371/journal.pone.0010992.

Nucleic acid template and the risk of a PCR-Induced HIV-1 drug resistance mutation

Affiliations

Nucleic acid template and the risk of a PCR-Induced HIV-1 drug resistance mutation

Vici Varghese et al. PLoS One. .

Abstract

Background: The HIV-1 nucleoside RT inhibitor (NRTI)-resistance mutation, K65R confers intermediate to high-level resistance to the NRTIs abacavir, didanosine, emtricitabine, lamivudine, and tenofovir; and low-level resistance to stavudine. Several lines of evidence suggest that K65R is more common in HIV-1 subtype C than subtype B viruses.

Methods and findings: We performed ultra-deep pyrosequencing (UDPS) and clonal dideoxynucleotide sequencing of plasma virus samples to assess the prevalence of minority K65R variants in subtype B and C viruses from untreated individuals. Although UDPS of plasma samples from 18 subtype C and 27 subtype B viruses showed that a higher proportion of subtype C viruses contain K65R (1.04% vs. 0.25%; p<0.001), limiting dilution clonal sequencing failed to corroborate its presence in two of the samples in which K65R was present in >1.5% of UDPS reads. We therefore performed UDPS on clones and site-directed mutants containing subtype B- and C-specific patterns of silent mutations in the conserved KKK motif encompassing RT codons 64 to 66 and found that subtype-specific nucleotide differences were responsible for increased PCR-induced K65R mutation in subtype C viruses.

Conclusions: This study shows that the RT KKK nucleotide template in subtype C viruses can lead to the spurious detection of K65R by highly sensitive PCR-dependent sequencing techniques. However, the study is also consistent with the subtype C nucleotide template being inherently responsible for increased polymerization-induced K65R mutations in vivo.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. Comparison of Ultra-Deep Pyrosequencing (UDPS) Results of Subtype B and Subtype C Clinical HIV-1 Samples.
Proportion of UDPS reads containing K65R in 18 subtype C and 27 subtype B viruses from anti retroviral-naïve individuals. For 16 of the 18 subtype C samples, UDPS was performed twice. The figure shows the mean proportion of K65R for the duplicate runs. The median proportion of K65R reads per sample were 0.25% for subtype B and 1.04% for subtype C.

References

    1. Gallant JE, Rodriguez AE, Weinberg WG, Young B, Berger DS, et al. Early Virologic Nonresponse to Tenofovir, Abacavir, and Lamivudine in HIV-Infected Antiretroviral-Naive Subjects. J Infect Dis. 2005;192:1921–1930. - PubMed
    1. Parikh UM, Koontz DL, Chu CK, Schinazi RF, Mellors JW. In vitro activity of structurally diverse nucleoside analogs against human immunodeficiency virus type 1 with the K65R mutation in reverse transcriptase. Antimicrob Agents Chemother. 2005;49:1139–1144. - PMC - PubMed
    1. Rhee SY, Taylor J, Wadhera G, Ben-Hur A, Brutlag DL, et al. Genotypic predictors of human immunodeficiency virus type 1 drug resistance. Proc Natl Acad Sci U S A. 2006;103:17355–17360. - PMC - PubMed
    1. Brenner BG, Oliveira M, Doualla-Bell F, Moisi DD, Ntemgwa M, et al. HIV-1 subtype C viruses rapidly develop K65R resistance to tenofovir in cell culture. AIDS. 2006;20:F9–13. - PubMed
    1. Doualla-Bell F, Avalos A, Brenner B, Gaolathe T, Mine M, et al. High prevalence of the K65R mutation in human immunodeficiency virus type 1 subtype C isolates from infected patients in Botswana treated with didanosine-based regimens. Antimicrob Agents Chemother. 2006;50:4182–4185. - PMC - PubMed

Publication types

LinkOut - more resources